Covidien is:

• A large global healthcare company committed to sustaining strong margins and cash flows while making investments for growth
• A leading manufacturer of medical devices and supplies, diagnostic imaging agents and pharmaceuticals, with 2009 revenue of $10.7 billion and industry-leading profit margins
• 42,000 employees worldwide in more than 60 countries, with products sold in over 140 countries
• Dedicated to R&D, spending nearly $438 million in 2009 alone, with that amount expected to increase in 2010
• Committed to creating innovative medical solutions for better patient outcomes and delivering value through clinical leadership and excellence

Covidien's business segments:

• Medical Devices - Includes endomechanical, soft tissue repair, energy, oximetry and monitoring, airway and ventilation, vascular and other products.
• Pharmaceuticals – Includes specialty pharmaceuticals, active pharmaceutical ingredients, specialty chemicals, contrast products and radiopharmaceuticals.
• Medical Supplies - Includes nursing care, medical surgical, SharpSafety and OEM products.

Covidien provides:

• Advanced surgical tools and supplies
• Sutures and wound care products
• Needles and syringes
• Contrast media for diagnostic imaging
• Vascular therapy
• Respiratory care devices
• Generic pharmaceuticals

Key brands:

• Kendall
• Autosuture
• Valleylab
• Mallinckrodt
• Nellcor
• Puritan Bennett

Medical, surgical, electrosurgical, respiratory therapy and imaging products are supplied to all of the following:

• Hospitals
• Acute care facilities
• Nursing homes
• Rehab centers
• Ambulatory surgery centers
• Physician offices
• Radiopharmacies

High quality products with instantly recognizable names that provide the basis for improved patient outcomes:

• Monoject Magellan™ Safety Needle
• Valleylab™ RF Ablation System
• Kangaroo ePump™ Enteral Feeding Pump
• Optivantage™ DH Dual Head Injector